Please log in to view this page
Username
Password
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
